Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Andreoni

Showing results (51-60 of 306) with videos related to

Pageof 31
Sort By:
AIDS (London, England)|July 4, 2006
Drug-resistance mutations can be archived very early in HIV primary infectionSaverio G Parisi, Romualdo Mazzi, Caterina Boldrin, et al.
Kardiochirurgia I Torakochirurgia Polska = Polish Journal of Cardio-Thoracic Surgery|November 29, 2017
Paravalvular leak of a mechanical mitral valve prosthesis associated with <i>Burkholderia cepacia</i> subacute endocarditis: a rare case successfully treated by multidisciplinary approachMarco Russo, Paolo Nardi, Guglielmo Saitto, et al.
Journal of Clinical Microbiology|February 5, 2002
Discordance between genotypic and phenotypic drug resistance profiles in human immunodeficiency virus type 1 strains isolated from peripheral blood mononuclear cellsLoredana Sarmati, Emanuele Nicastri, Saverio G Parisi, et al.
BMC Infectious Diseases|January 5, 2022
Meet-Test-Treat for HCV management: patients' and clinicians' preferences in hospital and drug addiction services in ItalyMassimo Andreoni, Nicola Coppola, Antonio Craxì, et al.
The New Microbiologica|February 21, 2019
Italian expert panel consensus statements on two-drug antiretroviral regimens to treat naïve and virologically suppressed HIV-1 infected patientsAndrea Antinori, Maria Mercedes Santoro, Roberta Gagliardini, et al.
Le Infezioni in Medicina|March 13, 2023
The future for COVID-19 vaccines: public health assessment and perspectives based on scientific evidenceMassimo Andreoni, Paolo Bonanni, Andrea Cossarizza, et al.
Journal of Personalized Medicine|May 27, 2023
T Lymphocyte Subset Counts and Interferon-Gamma Production in Adults and Children with COVID-19: A Narrative ReviewDomenico Umberto De Rose, Pier Giorgio Pace, Francesca Ceccherini-Silberstein, et al.
Current HIV Research|March 30, 2011
Once-a-day (QD) vs. twice-daily (BID) nevirapine as simplification in PI-treated patients after 2 mos. of BID inductionRenato Maserati, Micaela Brandolini, Annamaria Cattelan, et al.
Immunology Letters|August 23, 2017
NK cells of HIV-1-infected patients with poor CD4<sup>+</sup> T-cell reconstitution despite suppressive HAART show reduced IFN-γ production and high frequency of autoreactive CD56<sup>bright</sup> cellsErica Giuliani, Lia Vassena, Silvia Di Cesare, et al.
Critical Reviews in Oncology/Hematology|March 9, 2026
Bispecific Antibodies in Solid Tumors: An Italian Association of Medical Oncology (AIOM) multidisciplinary Perspective on Immunology and VaccinationAngioletta Lasagna, Marzia Del Re, Romano Danesi, et al.
Pageof 31

Showing results (51-60 of 306) with videos related to

Sort By:
Pageof 31
AIDS (London, England)|July 4, 2006
Drug-resistance mutations can be archived very early in HIV primary infectionSaverio G Parisi, Romualdo Mazzi, Caterina Boldrin, et al.
Kardiochirurgia I Torakochirurgia Polska = Polish Journal of Cardio-Thoracic Surgery|November 29, 2017
Paravalvular leak of a mechanical mitral valve prosthesis associated with <i>Burkholderia cepacia</i> subacute endocarditis: a rare case successfully treated by multidisciplinary approachMarco Russo, Paolo Nardi, Guglielmo Saitto, et al.
Journal of Clinical Microbiology|February 5, 2002
Discordance between genotypic and phenotypic drug resistance profiles in human immunodeficiency virus type 1 strains isolated from peripheral blood mononuclear cellsLoredana Sarmati, Emanuele Nicastri, Saverio G Parisi, et al.
BMC Infectious Diseases|January 5, 2022
Meet-Test-Treat for HCV management: patients' and clinicians' preferences in hospital and drug addiction services in ItalyMassimo Andreoni, Nicola Coppola, Antonio Craxì, et al.
The New Microbiologica|February 21, 2019
Italian expert panel consensus statements on two-drug antiretroviral regimens to treat naïve and virologically suppressed HIV-1 infected patientsAndrea Antinori, Maria Mercedes Santoro, Roberta Gagliardini, et al.
Le Infezioni in Medicina|March 13, 2023
The future for COVID-19 vaccines: public health assessment and perspectives based on scientific evidenceMassimo Andreoni, Paolo Bonanni, Andrea Cossarizza, et al.
Journal of Personalized Medicine|May 27, 2023
T Lymphocyte Subset Counts and Interferon-Gamma Production in Adults and Children with COVID-19: A Narrative ReviewDomenico Umberto De Rose, Pier Giorgio Pace, Francesca Ceccherini-Silberstein, et al.
Current HIV Research|March 30, 2011
Once-a-day (QD) vs. twice-daily (BID) nevirapine as simplification in PI-treated patients after 2 mos. of BID inductionRenato Maserati, Micaela Brandolini, Annamaria Cattelan, et al.
Immunology Letters|August 23, 2017
NK cells of HIV-1-infected patients with poor CD4<sup>+</sup> T-cell reconstitution despite suppressive HAART show reduced IFN-γ production and high frequency of autoreactive CD56<sup>bright</sup> cellsErica Giuliani, Lia Vassena, Silvia Di Cesare, et al.
Critical Reviews in Oncology/Hematology|March 9, 2026
Bispecific Antibodies in Solid Tumors: An Italian Association of Medical Oncology (AIOM) multidisciplinary Perspective on Immunology and VaccinationAngioletta Lasagna, Marzia Del Re, Romano Danesi, et al.
Pageof 31